Dear Ultrasound Insider,
Ultrasound is an important modality for breast cancer screening and also differentiating benign lesions from malignant ones. But the modality can produce high false-positive rates, leading to unnecessary biopsies and making the problem of reducing biopsies of benign lesions without missing cancers a key clinical issue.
How can the issue be addressed? Chinese researchers say that using a combination of elastography techniques with conventional ultrasound can help women avoid unnecessary biopsies of BI-RADS 4 lesions without missing cancers. Find out more in the study we're highlighting in this month's Insider Exclusive.
After you've read our featured story, take a look at what else is going on in the Ultrasound Community:
- Find why echocardiography is the top modality in Canada for heart failure.
- Read how adding focused cardiac ultrasonography to clinical assessment of the cardiovascular health of patients at bedside improves diagnostic yield.
- Does the imaging modality used to detect ductal carcinoma in situ influence recurrence? South Korean researchers say yes.
- Discover how using ultrasound with shear-wave elastography can distinguish benign from malignant breast microcalcifications originally identified on ultrasound.
- Check out how augmented reality can improve the performance of ultrasound image guidance.
If you have a comment or report to share about any aspect of ultrasound imaging, I invite you to contact me.
